Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000899243-19-025205
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-07 19:53:03
Reporting Period:
2019-10-07
Accepted Time:
2019-10-07 19:53:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1781983 Aprea Therapeutics Inc. APRE () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1645161 Healthcap Vii, L.p. C/o Healthcap Vii Gp S.a.
18 Avenue Of D'ouchy
Lausanne V8 CH-1006
No No Yes No
1790047 S.a. Gp Vii Healthcap C/o Healthcap Vii Gp S.a.,
18 Avenue Of D'ouchy
Lausanne V8 CH-1006
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-07 1,661,382 $0.00 1,671,941 No 4 C Indirect See footnote
Common Stock Acquisiton 2019-10-07 427,496 $0.00 2,099,437 No 4 C Indirect See footnote
Common Stock Acquisiton 2019-10-07 266,667 $15.00 2,366,104 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See footnote
No 4 C Indirect See footnote
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Convertible Preferred Stock Disposition 2019-10-07 1,661,382 $0.00 1,661,382 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2019-10-07 427,496 $0.00 427,496 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Immediately prior the closing of the Issuer's initial public offering the shares of preferred stock automatically converted into shares of the common stock. Each share of preferred stock was convertible into shares of common stock at any time at the option of the holder and had no expiration date.
  2. The securities are directly held by HealthCap VII L.P. (the "Fund"). HealthCap VII GP S.A. (the "General Partner") is the sole general partner of the Fund. The General Partner disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of its indirect pecuniary interest therein, and this report shall not be deemed an admission that the General Partner is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.